TrialPLoS medicine2022

Effect of glutamate infusion on NT-proBNP after coronary artery bypass grafting in high-risk patients (GLUTAMICS II): A randomized controlled trial.

Jonas Holm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.